Marker Therapeutics Financial Overview
Marker Therapeutics's market cap is currently $23.68M. The company's EPS TTM is $-0.12; its P/E ratio is -1.10; Marker Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
